TipRanks
Innate Pharma SA (DE:IDD)
XETRA:IDD
Germany Market
IDD
Innate Pharma SA
RESEARCH TOOLSreports

Innate Pharma SA (IDD) Stock News & Sentiment

1 Followers
Innate Pharma-Sobi Partnership Closes, Unlocks $75 Million and Phase 3 Lacutamab Trial
Premium
Company Announcements
Innate Pharma-Sobi Partnership Closes, Unlocks $75 Million and Phase 3 Lacutamab Trial
2h ago
Innate Pharma to deliver H1 2026 business update via investor webcast
Premium
Company Announcements
Innate Pharma to deliver H1 2026 business update via investor webcast
7d ago
Innate Pharma to Highlight Oncology Pipeline at H.C. Wainwright Investment Conference
Premium
Company Announcements
Innate Pharma to Highlight Oncology Pipeline at H.C. Wainwright Investment Conference
15d ago
Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference
Premium
Company Announcements
Innate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference
15d ago
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
Premium
Company Announcements
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
28d ago
6K
Innate Pharma Schedules Investor Call as Oncology Pipeline Advances
Premium
Company Announcements
Innate Pharma Schedules Investor Call as Oncology Pipeline Advances
1M ago
Innate Pharma Raises €30 Million in Share Offering to Extend Cash Runway
Premium
Company Announcements
Innate Pharma Raises €30 Million in Share Offering to Extend Cash Runway
1M ago
More DE:IDD News >

IDD News on the Web

Innate Pharma to deliver H1 2026 business update via investor webcast
TipRanks News
Neutral
Innate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline
TipRanks News
Bullish
Innate Pharma Schedules Investor Call as Oncology Pipeline Advances
TipRanks News
Bullish
Innate Pharma CMO Sonia Quaratino to depart, Markus Jensen to succeed
TipRanks News
Bullish
Innate Pharma Secures Funding and Advances Lacutamab to Phase 3 With New CMO
TipRanks News
Bullish
Innate Pharma CMO to Spotlight Cancer Pipeline at BTIG Bladder Cancer Panel
TipRanks News
Bullish
Innate Pharma completes enrollment in dose escalation of IPH4502 study
TipRanks News
Bullish
Innate Pharma Reports Voting Outcomes from 2026 Annual General Meeting
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:IDD
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.75 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:IDD’s Media Buzz Sentiment?
1 articles about DE:IDD were published this week. In an average week, 1.75 articles are published.
    What is DE:IDD’s weekly average amount of articles?
    In an average week, 1.75 articles about DE:IDD are published.
      What is DE:IDD’s News Sentiment?
      50% of articles about DE:IDD were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AXGNAxoGen
        BAYRYBayer
        HITIHigh Tide
        JAZZJazz Pharmaceuticals
        DXCMDexcom
        Showing the stocks with the most bullish news sentiment over the past week